share_log

Icade (OTCMKTS:CDMGF) Downgraded by Exane BNP Paribas to "Neutral"

Icade (OTCMKTS:CDMGF) Downgraded by Exane BNP Paribas to "Neutral"

法國巴黎銀行將iCade(OTCMKTS:CDMGF)評級下調至“中性”
Defense World ·  2022/09/27 03:01

Exane BNP Paribas downgraded shares of Icade (OTCMKTS:CDMGF – Get Rating) from an outperform rating to a neutral rating in a research note published on Monday, The Fly reports. The firm currently has €41.00 ($41.84) price objective on the stock.

據The Fly報道,法國巴黎銀行在週一發佈的一份研究報告中,將Iade(場外交易市場代碼:CDMGF-GET Rating)的股票評級從強於大盤下調至中性。該公司目前對該股的目標價為41.00歐元(合41.84美元)。

Several other equities research analysts also recently issued reports on the company. Societe Generale lowered their price target on Icade from €81.50 ($83.16) to €68.50 ($69.90) and set a buy rating for the company in a report on Friday, June 17th. Barclays lowered their price target on Icade from €70.00 ($71.43) to €65.00 ($66.33) in a report on Tuesday, July 5th. Deutsche Bank Aktiengesellschaft lowered their price target on Icade from €74.00 ($75.51) to €50.00 ($51.02) and set a hold rating for the company in a report on Wednesday, June 15th. JPMorgan Chase & Co. reduced their price objective on Icade from €70.00 ($71.43) to €55.00 ($56.12) in a research report on Monday, September 19th. Finally, UBS Group reduced their price objective on Icade from €75.00 ($76.53) to €60.00 ($61.22) and set a buy rating for the company in a research report on Tuesday, August 16th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of Hold and an average price target of $58.96.

其他幾位股票研究分析師最近也發佈了關於該公司的報告。法國興業銀行將Iade的目標價從81.50歐元(83.16美元)下調至68.50歐元(69.90美元),並在6月17日週五的一份報告中為該公司設定了買入評級。巴克萊在7月5日週二的一份報告中將Iade的目標價從70.00歐元(71.43美元)下調至65.00歐元(66.33美元)。德意志銀行Aktiengesellschaft在6月15日週三的一份報告中將Iade的目標價從74.00歐元(75.51美元)下調至50.00歐元(51.02美元),併為該公司設定了持有評級。摩根大通在9月19日週一的一份研究報告中將Iade的目標價從70.00歐元(71.43美元)下調至55.00歐元(56.12美元)。最後,瑞銀集團將Iade的目標價從75.00歐元(76.53美元)下調至60.00歐元(61.22美元),並在8月16日(星期二)的一份研究報告中為該公司設定了買入評級。一名投資分析師對該股的評級為賣出,三名分析師給出了持有評級,三名分析師給出了該公司股票的買入評級。根據MarketBeat.com的數據,該公司目前的普遍評級為持有,平均目標價為58.96美元。

Get
到達
Icade
ICade
alerts:
警報:

Icade Stock Performance

ICade股票表現

Shares of Icade stock opened at $38.00 on Monday. Icade has a 1 year low of $38.00 and a 1 year high of $79.30. The business has a 50-day moving average of $46.86 and a two-hundred day moving average of $53.91.

週一,Iade的股票開盤報38.00美元。ICade的一年低點為38.00美元,一年高位為79.30美元。該業務的50日移動均線切入位在46.86美元,200日移動均線切入位在53.91美元。

About Icade

關於Iade

(Get Rating)
(獲取評級)

As an investor and a developer, Icade is an integrated real estate player that designs innovative real estate products and services adapted to new urban lifestyles and habits. By placing corporate social responsibility and innovation at the core of its strategy, Icade is closely involved with stakeholders and users in the citieslocal authorities and communities, companies and employees, institutions and associations.

作為一家投資者和開發商,Iade是一家綜合房地產公司,設計適應新的城市生活方式和習慣的創新房地產產品和服務。通過將企業社會責任和創新作為其戰略的核心,Iade與各城市的利益相關者和用户、地方當局和社區、公司和員工、機構和協會密切合作。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Icade (CDMGF)
  • MO Money: Why Altria Group Stock is Rallying
  • Is the Market Overreacting with Shopify Stock?
  • Fed Raises Rates: 3 Stocks to Watch Newmont Mining, Walmart, AMC
  • Three Consumer Stocks That Could Outperform In Q4
  • Comcast is an Asset Bonanza Priced Cheap
  • 免費獲取StockNews.com關於Iade的研究報告(CDMGF)
  • Mo Money:奧馳亞集團股價為何上漲
  • 市場是否對Shopify Stock反應過度?
  • 美聯儲加息:3只股票關注紐蒙特礦業、沃爾瑪、AMC
  • 三隻可能在第四季度表現優異的消費類股
  • 康卡斯特是廉價的資產財源

Receive News & Ratings for Icade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icade and related companies with MarketBeat.com's FREE daily email newsletter.

接受Iade Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Iade和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論